최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0737671 (2007-04-19) |
등록번호 | US-8480580 (2013-07-09) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 3 인용 특허 : 1653 |
An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing
An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
1. A medication management device, comprising: a communication interface configured to receive one or more data associated with a monitored analyte level; anda processor coupled to the communication interface, the processor configured to detect or predict a predetermined rate of change or level base
1. A medication management device, comprising: a communication interface configured to receive one or more data associated with a monitored analyte level; anda processor coupled to the communication interface, the processor configured to detect or predict a predetermined rate of change or level based on the received one or more data associated with the monitored analyte level, wherein the processor is configured to prompt a user to disable one or more medication related functions when the detected predetermined rate of change deviates from a predefined threshold level, to receive a request to disable the one or more, medication related functions, and to disable the one or more, medication related functions upon receipt of the request. 2. The device of claim 1 wherein the predetermined rate of change includes a decrease in the analyte level of the user. 3. The device of claim 1 wherein the one or more medication related functions includes one or more medication or carbohydrate administration functions. 4. The device of claim 1 wherein the processor is configured to temporarily disable the one or more medication related functions until the predicted or detected predetermined rate of change or level substantially falls within the predefined threshold level. 5. The device of claim 1 wherein the predefined threshold level includes a hypoglycemic condition, an impending hypoglycemic condition, a hyperglycemic condition or an impending hyperglycemic condition. 6. The device of claim 1 wherein the processor is further configured to determine an increase in the risk of an adverse physiological condition, and to modify the predefined threshold level when the increase in the risk of the adverse physiological condition is determined. 7. The device of claim 6 wherein the increase in the risk of the adverse physiological condition is determined based on a retrospective analysis using a determined blood glucose index. 8. A method, comprising: predicting or detecting, using one or more processors, a predetermined rate of change or level based on one or more data associated with a monitored analyte level;prompting, using the one or more processors, a user to disable one or more medication related functions of a medical device when the detected predetermined rate of change deviates from a predefined threshold level;receiving, using the one or more processors, a request to disable the one or more medication related functions; anddisabling, using the one or more processors, the one or more medication related functions upon receipt of the request. 9. The method of claim 8 wherein disabling includes temporarily disabling one or more executable functions of the medical device related to an infusion of a medication. 10. The method of claim 8 wherein the disabling includes temporarily disabling the one or more medication related functions of the medical device until the predicted or detected predetermined rate of change or level substantially falls within the predefined threshold level. 11. The device of claim 8 wherein the predefined threshold level includes a hypoglycemic condition, an impending hypoglycemic condition, a hyperglycemic condition or an impending hyperglycemic condition. 12. The method of claim 8 further comprising: determining an increase in the risk of an adverse physiological condition; andmodifying the predefined threshold level when the increase in the risk of the adverse physiological condition is determined. 13. The method of claim 12 wherein the increase in the risk of the adverse physiological condition is determined based on a retrospective analysis using a determined blood glucose index.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.